$MLAB
MESA LABORATORIES INC /CO/

2020 Q2 Form 10-Q Financial Statement

#000143774920016748 Filed on August 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $29.94M $26.29M
YoY Change 13.9% 4.56%
Cost Of Revenue $9.601M $10.15M
YoY Change -5.4% 0.98%
Gross Profit $20.34M $16.20M
YoY Change 25.52% 7.38%
Gross Profit Margin 67.93% 61.64%
Selling, General & Admin $14.17M $9.728M
YoY Change 45.7% 2.51%
% of Gross Profit 69.69% 60.03%
Research & Development $2.596M $1.019M
YoY Change 154.76% 21.74%
% of Gross Profit 12.76% 6.29%
Depreciation & Amortization $3.908M $2.181M
YoY Change 79.18% -11.16%
% of Gross Profit 19.21% 13.46%
Operating Expenses $16.77M $10.75M
YoY Change 56.04% 4.07%
Operating Profit $3.570M $5.392M
YoY Change -33.79% 13.18%
Interest Expense $1.919M $395.0K
YoY Change 385.82%
% of Operating Profit 53.75% 7.33%
Other Income/Expense, Net -$2.816M -$32.00K
YoY Change 8700.0% -91.21%
Pretax Income $754.0K $5.360M
YoY Change -85.93% 21.82%
Income Tax -$463.0K $763.0K
% Of Pretax Income -61.41% 14.24%
Net Earnings $1.217M $4.660M
YoY Change -73.88% 10.17%
Net Earnings / Revenue 4.06% 17.73%
Basic Earnings Per Share $0.27 $1.20
Diluted Earnings Per Share $0.26 $1.14
COMMON SHARES
Basic Shares Outstanding 4.528M 3.901M
Diluted Shares Outstanding 4.669M 4.086M

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $231.0M $7.300M
YoY Change 3064.38% -1.35%
Cash & Equivalents $231.0M $7.315M
Short-Term Investments
Other Short-Term Assets $8.000M $6.600M
YoY Change 21.21% 53.49%
Inventory $12.90M $6.971M
Prepaid Expenses
Receivables $17.93M $12.95M
Other Receivables $0.00 $0.00
Total Short-Term Assets $269.8M $33.82M
YoY Change 697.53% 3.02%
LONG-TERM ASSETS
Property, Plant & Equipment $21.80M $21.98M
YoY Change -0.85% -5.65%
Goodwill $153.9M $67.42M
YoY Change 128.33% 3.58%
Intangibles $117.5M $33.75M
YoY Change 248.18% -15.85%
Long-Term Investments
YoY Change
Other Assets $2.254M $1.361M
YoY Change 65.61% 1261.0%
Total Long-Term Assets $307.0M $125.8M
YoY Change 143.93% -2.16%
TOTAL ASSETS
Total Short-Term Assets $269.8M $33.82M
Total Long-Term Assets $307.0M $125.8M
Total Assets $576.7M $159.7M
YoY Change 261.2% -1.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.812M $3.130M
YoY Change -10.16% 8.95%
Accrued Expenses $5.944M $4.792M
YoY Change 24.04% 44.29%
Deferred Revenue $5.858M $4.086M
YoY Change 43.37%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.250M
YoY Change 28.57%
Total Short-Term Liabilities $20.48M $21.32M
YoY Change -3.98% 36.35%
LONG-TERM LIABILITIES
Long-Term Debt $141.6M $17.51M
YoY Change 708.59% -53.5%
Other Long-Term Liabilities $1.190M $696.0K
YoY Change 70.98% 278.26%
Total Long-Term Liabilities $1.190M $18.21M
YoY Change -93.46% -51.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.48M $21.32M
Total Long-Term Liabilities $1.190M $18.21M
Total Liabilities $194.5M $40.62M
YoY Change 378.78% -27.47%
SHAREHOLDERS EQUITY
Retained Earnings $72.24M $77.28M
YoY Change -6.51% 7.48%
Common Stock $306.9M $43.40M
YoY Change 607.1% 26.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $382.2M $119.0M
YoY Change
Total Liabilities & Shareholders Equity $576.7M $159.7M
YoY Change 261.2% -1.11%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $1.217M $4.660M
YoY Change -73.88% 10.17%
Depreciation, Depletion And Amortization $3.908M $2.181M
YoY Change 79.18% -11.16%
Cash From Operating Activities $2.260M $724.0K
YoY Change 212.15% -88.93%
INVESTING ACTIVITIES
Capital Expenditures $216.0K $226.0K
YoY Change -4.42% -175.33%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$2.560M
YoY Change -100.0%
Cash From Investing Activities -$216.0K -$2.781M
YoY Change -92.23% 827.0%
FINANCING ACTIVITIES
Cash Dividend Paid $704.0K $624.0K
YoY Change 12.82% 2.3%
Common Stock Issuance & Retirement, Net $145.9M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $146.9M -$915.0K
YoY Change -16153.01% -79.4%
NET CHANGE
Cash From Operating Activities $2.260M $724.0K
Cash From Investing Activities -$216.0K -$2.781M
Cash From Financing Activities $146.9M -$915.0K
Net Change In Cash $149.6M -$2.870M
YoY Change -5311.53% -259.36%
FREE CASH FLOW
Cash From Operating Activities $2.260M $724.0K
Capital Expenditures $216.0K $226.0K
Free Cash Flow $2.044M $498.0K
YoY Change 310.44% -92.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2020Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
230951000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
9315000 USD
CY2020Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2019Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5103451
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
188000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
159000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13157000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12741000 USD
CY2020Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5102939
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5102939
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4387140
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4387140
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81380000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17929000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21132000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
12900000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
14230000 USD
CY2020Q2 us-gaap Prepaid Taxes
PrepaidTaxes
2719000 USD
CY2020Q1 us-gaap Prepaid Taxes
PrepaidTaxes
1914000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5257000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4136000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
269756000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
122792000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21796000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22066000 USD
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11453000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11461000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2254000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2812000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3408000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5341000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8940000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2480000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
117526000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
119871000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
153948000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
141536000 USD
CY2020Q2 us-gaap Assets
Assets
576733000 USD
CY2020Q1 us-gaap Assets
Assets
420206000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1019000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
16770000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
10747000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3198000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5392000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
1919000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5858000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6814000 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
520000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
504000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5944000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6342000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
20475000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
26008000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
31230000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
32549000 USD
CY2020Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
141604000 USD
CY2020Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
140278000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1190000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1358000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
194499000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
200193000 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
306880000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
158023000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
72242000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
71930000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3112000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9940000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
382234000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
220013000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
576733000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
420206000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29941000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26288000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
9973000 USD
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
10149000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
19968000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
16139000 USD
CY2020Q2 us-gaap Selling Expense
SellingExpense
4075000 USD
CY2019Q2 us-gaap Selling Expense
SellingExpense
2208000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10099000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7520000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2596000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
395000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-897000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
363000 USD
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.18
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2816000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
382000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5360000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-643000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
763000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1025000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4597000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2068000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
724000 USD
CY2020Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
-0 USD
CY2019Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
2555000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
216000 USD
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
226000 USD
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4528000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3901000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4669000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4086000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1025000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4597000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13052000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
186000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14077000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4783000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1025000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4597000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3908000 USD
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2181000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1268000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
868000 USD
CY2020Q2 us-gaap Paid In Kind Interest
PaidInKindInterest
1326000 USD
CY2020Q2 mlab Amortization Of Inventory Stepup Cost
AmortizationOfInventoryStepupCost
-436000 USD
CY2020Q2 mlab Increase Decrease In Inventory Reserve
IncreaseDecreaseInInventoryReserve
-47000 USD
CY2019Q2 mlab Increase Decrease In Inventory Reserve
IncreaseDecreaseInInventoryReserve
-197000 USD
CY2020Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-360000 USD
CY2019Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-0 USD
CY2020Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-84000 USD
CY2019Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-64000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4251000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
587000 USD
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1194000 USD
CY2019Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-86000 USD
CY2020Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1982000 USD
CY2019Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2579000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-913000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
50000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4377000 USD
CY2019Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4272000 USD
CY2020Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1299000 USD
CY2019Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
119000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-216000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2781000 USD
CY2020Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
145935000 USD
CY2020Q2 us-gaap Repayments Of Debt
RepaymentsOfDebt
-0 USD
CY2019Q2 us-gaap Repayments Of Debt
RepaymentsOfDebt
3000000 USD
CY2020Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
704000 USD
CY2019Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
624000 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1654000 USD
CY2019Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2709000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
146885000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-915000 USD
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
834000 USD
CY2019Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
102000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
149571000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2870000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
81380000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10185000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
230951000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7315000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
220013000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
145935000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1654000 USD
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
704000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1268000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13052000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1025000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
382234000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
111311000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2709000 USD
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
624000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
868000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
186000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4597000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
119047000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 pure
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29941000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26288000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29941000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26288000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7217000 USD
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1907000 USD
CY2020Q2 mlab Contract With Customer Liability Increase During Period Net Of Revenue Recognized
ContractWithCustomerLiabilityIncreaseDuringPeriodNetOfRevenueRecognized
879000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6189000 USD
CY2020Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
214778000 USD
CY2020Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
66735000 USD
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
7665000 USD
CY2020Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
6757000 USD
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
324000 USD
CY2020Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
329000 USD
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7582000 USD
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9768000 USD
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2671000 USD
CY2020Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2624000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
12900000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
14230000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
170620000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
53094000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
117526000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
169123000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
49252000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
119871000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3354000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1672000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
14813000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
14448000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
14240000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
13724000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
12129000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
141536000 USD
CY2020Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
5869000 USD
CY2020Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2020Q2 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
6543000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
153948000 USD
CY2020Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1122000 USD
CY2020Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4069000 USD
CY2020Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2128000 USD
CY2020Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2485000 USD
CY2020Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1957000 USD
CY2020Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2228000 USD
CY2020Q2 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
134000 USD
CY2020Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
158000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5341000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8940000 USD
CY2020Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
2851000 USD
CY2020Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
3796000 USD
CY2020Q2 us-gaap Interest Payable Current
InterestPayableCurrent
889000 USD
CY2020Q1 us-gaap Interest Payable Current
InterestPayableCurrent
296000 USD
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
382000 USD
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
857000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
807000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
298000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5944000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6342000 USD
CY2020Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
593000 USD
CY2019Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
0 USD
CY2020Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1326000 USD
CY2019Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1919000 USD
CY2019Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
0 USD
CY2020Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
600000
CY2020Q2 mlab Sale Of Stock Underwriter Options Shares
SaleOfStockUnderwriterOptionsShares
90000
CY2020Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
225.00
CY2020Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
145935000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1268000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
868000 USD
CY2020Q2 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-925000 USD
CY2019Q2 mlab Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense
EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense
-540000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
343000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
328000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
286000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
107.72
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
36000
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
226.72
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
10000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
112.93
CY2020Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
23000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
78.31
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
289000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
124.74
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1025000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4597000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4528000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3901000
CY2020Q2 mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
130000
CY2019Q2 mlab Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
175000
CY2020Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
11000
CY2019Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
10000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4669000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4086000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.18
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5360000 USD
CY2020Q2 us-gaap Assets
Assets
576733000 USD
CY2020Q1 us-gaap Assets
Assets
420206000 USD
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
661000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20000
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.683 pure
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.142 pure
CY2019Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2019Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-746000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 pure
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29941000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
19968000 USD
CY2020Q2 mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-19586000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
382000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26288000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
16139000 USD
CY2019Q2 mlab General And Administrative Research And Development Other Expense
GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
-10779000 USD

Files In Submission

Name View Source Status
0001437749-20-016748-index-headers.html Edgar Link pending
0001437749-20-016748-index.html Edgar Link pending
0001437749-20-016748.txt Edgar Link pending
0001437749-20-016748-xbrl.zip Edgar Link pending
ex_189465.htm Edgar Link pending
ex_189466.htm Edgar Link pending
ex_189467.htm Edgar Link pending
ex_189468.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mlab-20200630.xsd Edgar Link pending
mlab-20200630_cal.xml Edgar Link unprocessable
mlab-20200630_def.xml Edgar Link unprocessable
mlab-20200630_lab.xml Edgar Link unprocessable
mlab-20200630_pre.xml Edgar Link unprocessable
mlab20200630_10q.htm Edgar Link pending
mlab20200630_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending